MSD reinstated to ABPI membership

Published: 4-Jan-2007

Merck Sharp and Dohme (MSD) has been reinstated to membership of the Association of the British Pharmaceutical Industry (ABPI) following the company's suspension in October 2006.


Merck Sharp and Dohme (MSD) has been reinstated to membership of the Association of the British Pharmaceutical Industry (ABPI) following the company's suspension in October 2006.

The ABPI Board of Management noted that the importance of complying with the ABPI Code of Practice had been made clear to all MSD staff, and an audit report in November referred to the company's commitment to compliance and its progress in recent months. The ABPI Board agreed that the momentum generated needed to be maintained and a further audit will be carried out within six months.

MSD was suspended from membership for a minimum of three months after it was found to be in breach of the code, including Clause 2 which deals with activities that bring discredit on, or reduce confidence in, the pharmaceutical industry.

You may also like